UK markets open in 7 hours 3 minutes

Bone Biologics Corporation (BBLG)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.6777-0.0223 (-1.31%)
At close: 04:00PM EDT
1.6699 -0.01 (-0.46%)
After hours: 04:01PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.47M
Enterprise value -1.55M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.51
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.16

Trading information

Stock price history

Beta (5Y monthly) 0.58
52-week change 3-96.96%
S&P500 52-week change 323.42%
52-week high 372.0000
52-week low 31.6200
50-day moving average 32.6010
200-day moving average 35.1626

Share statistics

Avg vol (3-month) 386.18k
Avg vol (10-day) 339.8k
Shares outstanding 5879.18k
Implied shares outstanding 6879.18k
Float 8480.93k
% held by insiders 18.15%
% held by institutions 11.26%
Shares short (28 Mar 2024) 415.11k
Short ratio (28 Mar 2024) 40.1
Short % of float (28 Mar 2024) 41.78%
Short % of shares outstanding (28 Mar 2024) 41.72%
Shares short (prior month 29 Feb 2024) 4124.81k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 324 Jul 2018
Ex-dividend date 4N/A
Last split factor 21:8
Last split date 320 Dec 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-96.34%
Return on equity (ttm)-202.15%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-8.95M
Diluted EPS (ttm)-34.0100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.03M
Total cash per share (mrq)5.66
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)4.50
Book value per share (mrq)5.44

Cash flow statement

Operating cash flow (ttm)-9.56M
Levered free cash flow (ttm)-7.21M